Details
Description
The purpose of this analysis was to describe the baseline characteristics and duration of follow-up time among new users of 20 new molecular entities (NMEs) approved in 2005, 22 NMEs approved in 2006, and 17 NMEs approved in 2007 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD). We distributed this request to 17 Sentinel Data Partners on December 21, 2018.
This analysis contains three reports:
- Report 1: This report contains data on users of NMEs approved in 2005. The study period was from January 1, 2005 to June 30, 2018.
- Report 2:This report contains data on users of NMEs approved in 2006. The study period was from January 1, 2006 to June 30, 2018.
- Report 3:This report contains data on users of NMEs approved in 2007. The study period was from January 1, 2007 to June 30, 2018.
Deliverables (3)
Sentinel Modular Program Report: Duration of Follow Up for New Molecular Entities Approved in 2005, Report 1
Sentinel Modular Program Report: Duration of Follow Up for New Molecular Entities Approved in 2006, Report 2
Sentinel Modular Program Report: Duration of Follow Up for New Molecular Entities Approved in 2007, Report 3